Chemotherapy Resistance and Sensitivity Testing in Lung Tumors

Inclusion Criteria:

• suspected or confirmed diagnosis of lung cancer

  • undergoing a fine needle aspiration, core biopsy, or excisional biopsy for diagnosis.
• Chemotherapy must be clinically indicated for treatment of the patient's qualifying disease
• Patient must be at least 18 years of age
• Patient must have signed an IRB approved informed consent form for the data collection study prior to entry of data into the enrollment form in the database.

Exclusion Criteria:

• Patient pathology shows benign pathology for sample submitted
• Patient is not indicated to receive chemotherapy for their disease